Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Gains 32 Points. More details...
CBT 200 Closes Higher; Nets Gain For Week. More details...
Event returns to San Francisco. More details...
CBT 200 Gains More Than 2%. More details...
No Benefit Seen In German Study. More details...
CBT 200 Gains 23 Points. More details...
Biotech Is Virtually Unchanged. More details...
CBT 200 Down 34 Points In Late Slide. More details...
CBT 200 Drops 34 Points. More details...
CBT 200 Is Up 9 Points. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
